Nassar, M.; Alzaidy, N.; Nasiri, A.; Hanbali, A.; Aljurf, M.A.; Mohammed Saleh, M.F.
Salvage or Second Autologous SCT in Relapsed Multiple Myeloma (2016–2026): A Decade in Review. Curr. Oncol. 2026, 33, 140.
https://doi.org/10.3390/curroncol33030140
AMA Style
Nassar M, Alzaidy N, Nasiri A, Hanbali A, Aljurf MA, Mohammed Saleh MF.
Salvage or Second Autologous SCT in Relapsed Multiple Myeloma (2016–2026): A Decade in Review. Current Oncology. 2026; 33(3):140.
https://doi.org/10.3390/curroncol33030140
Chicago/Turabian Style
Nassar, Marwa, Nourah Alzaidy, Abdulrahman Nasiri, Amr Hanbali, Mahmoud A. Aljurf, and Mostafa F. Mohammed Saleh.
2026. "Salvage or Second Autologous SCT in Relapsed Multiple Myeloma (2016–2026): A Decade in Review" Current Oncology 33, no. 3: 140.
https://doi.org/10.3390/curroncol33030140
APA Style
Nassar, M., Alzaidy, N., Nasiri, A., Hanbali, A., Aljurf, M. A., & Mohammed Saleh, M. F.
(2026). Salvage or Second Autologous SCT in Relapsed Multiple Myeloma (2016–2026): A Decade in Review. Current Oncology, 33(3), 140.
https://doi.org/10.3390/curroncol33030140